Details for New Drug Application (NDA): 016776
✉ Email this page to a colleague
NDA 016776 describes SORBITRATE, which is a drug marketed by Astrazeneca and is included in six NDAs. Additional details are available on the SORBITRATE profile page.
The generic ingredient in SORBITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
The generic ingredient in SORBITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Summary for 016776
| Tradename: | SORBITRATE |
| Applicant: | Astrazeneca |
| Ingredient: | isosorbide dinitrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016776
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 1, 1996 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 1, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
